-
Analysts are split on US Bancorp, but 12 of 26 analysts rate it hold.
FORBES: Earnings Preview: U.S. Bancorp
-
Either way, don't count on the analysts to alert us to problems ahead.
FORBES: Analyze This
-
While US analysts were fixated on whether the US market would correct or not, European markets were already correcting.
FORBES: The Week Ahead: Will Overseas Markets Lead the Way?
-
The move also has US-Cuba analysts questioning what effect the eased travel rules will have on US-Cuba relations.
BBC: Cuba lifts travel restrictions
-
Fresh economic data published by the US government on Friday morning showed the US economy growing at a 2% annual rate - twice what analysts had expected, but this did little to temper Mr Koehler's remarks.
BBC: IMF backs Turkey aid deal
-
In the US, analysts said the fact that the fees levied on banks would be spread out over a decade would diminish their impact.
BBC: Obama outlines $117bn bank levy
-
Analysts, though, have long led us astray on drug stocks.
FORBES: Drugs of Choice
-
Altria, the US maker of Marlboro, has stayed on the sidelines thus far, but analysts expect the tobacco giant to either acquire an e-cigarette manufacturer or launch its own brand soon.
CNN: Sales of e-cigarettes continue to soar
-
Currently the US and EU impose relatively low tariffs on goods traded between them, but analysts say other barriers are often in place to prevent European companies competing in the US and vice versa.
BBC: EU and US free-trade talks launched
-
"We're building a portfolio in this fiscal year, so you will see us getting into the market with various products, " Mr. Heins said on a conference call with analysts Thursday.
WSJ: RIM Places Risky BlackBerry Bet
-
As a relatively small number of stocks climb, the reporters and analysts tend to fixate on them to the exclusion of other, less dramatic occurrences that could be telling us something important about a coming crash.
FORBES: Study: Financial Reporters' Bubbly Word Choice Predicts Stock Market Bubbles